{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:29:28Z","timestamp":1784806168803,"version":"3.55.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FSGSK_1_2020_1_165443"],"award-info":[{"award-number":["FSGSK_1_2020_1_165443"]}],"id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024018","name":"Programa de Desarrollo de las Ciencias B\u00e1sicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["SNI"],"award-info":[{"award-number":["SNI"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88307-7","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:47:29Z","timestamp":1738763249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage"],"prefix":"10.1038","volume":"15","author":[{"given":"Diego","family":"Alem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar X.","family":"Garc\u00eda-Lavi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garagorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dardo","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquina","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Pazos-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Noel","family":"Cuiti\u00f1o-Mendiberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Villad\u00f3niga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Castro-Sowinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Fl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Madauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Canclini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"88307_CR1","doi-asserted-by":"crossref","unstructured":"Riek, R. The three-dimensional structures of amyloids. Cold Spring Harb Perspect. Biol. 9 (2017).","DOI":"10.1101\/cshperspect.a023572"},{"key":"88307_CR2","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1073\/pnas.0915166107","volume":"107","author":"L Goldschmidt","year":"2010","unstructured":"Goldschmidt, L., Teng, P. K., Riek, R. & Eisenberg, D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. U. S. A. 107, 3487\u20133492 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"88307_CR3","doi-asserted-by":"crossref","unstructured":"Taylor, A. I. P. & Staniforth, R. A. General principles underpinning amyloid structure. Front. Neurosci. 16 (2022).","DOI":"10.3389\/fnins.2022.878869"},{"key":"88307_CR4","doi-asserted-by":"crossref","unstructured":"Otzen, D. & Riek, R. Functional amyloids. Cold Spring Harb. Perspect. Biol. 11 (2019).","DOI":"10.1101\/cshperspect.a033860"},{"key":"88307_CR5","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1039\/D2SC00645F","volume":"13","author":"\u00dc Akbey","year":"2022","unstructured":"Akbey, \u00dc. & Andreasen, M. Functional amyloids from bacterial biofilms \u2013 structural properties and interaction partners. Chem. Sci. 13, 6457 (2022).","journal-title":"Chem. Sci."},{"key":"88307_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1173155","volume":"325","author":"SK Maji","year":"2009","unstructured":"Maji, S. K. et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328\u2013332 (2009).","journal-title":"Science"},{"key":"88307_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/15476286.2016.1244588","volume":"14","author":"IP Sudhakaran","year":"2017","unstructured":"Sudhakaran, I. P. & Ramaswami, M. Long-term memory consolidation: the role of RNA-binding proteins with prion-like domains. RNA Biol. 14, 568\u2013586 (2017).","journal-title":"RNA Biol."},{"key":"88307_CR8","doi-asserted-by":"crossref","unstructured":"Dobson, C. M. The amyloid phenomenon and its links with human disease. Cold Spring Harb. Perspect. Biol. 9 (2017).","DOI":"10.1101\/cshperspect.a023648"},{"key":"88307_CR9","doi-asserted-by":"crossref","unstructured":"Navalkar, A. et al. Direct evidence of cellular transformation by prion-like p53 amyloid infection. J. Cell. Sci. 134 (2021).","DOI":"10.1242\/jcs.258316"},{"key":"88307_CR10","doi-asserted-by":"crossref","unstructured":"Li, J. et al. p53 amyloid aggregation in cancer: function, mechanism, and therapy. Exp. Hematol. Oncol. 11 (2022).","DOI":"10.1186\/s40164-022-00317-7"},{"key":"88307_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.biocel.2010.10.017","volume":"43","author":"CB Levy","year":"2011","unstructured":"Levy, C. B. et al. Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors. Int. J. Biochem. Cell. Biol. 43, 60\u201364 (2011).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"88307_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.bbrc.2012.11.130","volume":"430","author":"CA Lasagna-Reeves","year":"2013","unstructured":"Lasagna-Reeves, C. A. et al. Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity. Biochem. Biophys. Res. Commun. 430, 963\u2013968 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"88307_CR13","doi-asserted-by":"crossref","unstructured":"Sengupta, S. et al. p53 amyloid pathology is correlated with higher cancer grade irrespective of the mutant or wild-type form. J. Cell. Sci. 136 (2023).","DOI":"10.1242\/jcs.261017"},{"key":"88307_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/path.4872","volume":"242","author":"F De Smet","year":"2017","unstructured":"De Smet, F. et al. Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. J. Pathol. 242, 24\u201338 (2017).","journal-title":"J. Pathol."},{"key":"88307_CR15","doi-asserted-by":"crossref","unstructured":"Sengupta, S., Ghufran, S. M., Khan, A., Biswas, S. & Roychoudhury, S. Transition of amyloid\/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness. Cancer Cell Int. 22, 1\u201318 (2022).","DOI":"10.1186\/s12935-022-02831-4"},{"key":"88307_CR16","doi-asserted-by":"crossref","unstructured":"Saginala, K. et al. Epidemiology of bladder cancer. Med. Sci. 8 (2020).","DOI":"10.3390\/medsci8010015"},{"key":"88307_CR17","doi-asserted-by":"crossref","unstructured":"Grabe-Heyne, K. et al. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Front. Oncol. 13 (2023).","DOI":"10.3389\/fonc.2023.1170124"},{"key":"88307_CR18","doi-asserted-by":"crossref","unstructured":"Ripoll, J. et al. Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival. BMC Cancer 21 (2021).","DOI":"10.1186\/s12885-021-08418-y"},{"key":"88307_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel, V. G., Oh, W. K. & Galsky, M. D. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70, 404\u2013423 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"88307_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of bladder Cancer in 2023: a systematic review of risk factors. Eur. Urol. 84, 176\u2013190 (2023).","journal-title":"Eur. Urol."},{"key":"88307_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176072","volume":"21","author":"T Hayashi","year":"2020","unstructured":"Hayashi, T. et al. Mutational landscape and environmental effects in bladder cancer. Int. J. Mol. Sci. 21, 1\u201314 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"88307_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles, T. et al. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up \u2606. Ann. Oncol. 33, 244\u2013258 (2022).","journal-title":"Ann. Oncol."},{"key":"88307_CR23","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1007\/s11033-023-08689-7","volume":"50","author":"L Schwarzova","year":"2023","unstructured":"Schwarzova, L., Novakova, V., Danisovic, Z., Ziaran, S. & L. & Molecular classification of urothelial bladder carcinoma. Mol. Biol. Rep. 50, 7867\u20137877 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"88307_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/14737140.2020.1744437","volume":"20","author":"T Goto","year":"2020","unstructured":"Goto, T. & Miyamoto, H. Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements? Expert Rev. Anticancer Ther. 20, 229\u2013231 (2020).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"88307_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/bjc.1970.89","volume":"24","author":"CC Rigby","year":"1970","unstructured":"Rigby, C. C. & Franks, L. M. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br. J. Cancer 24, 746\u2013754 (1970).","journal-title":"Br. J. Cancer"},{"key":"88307_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ijc.2910110327","volume":"11","author":"J Buben\u00edk","year":"1973","unstructured":"Buben\u00edk, J. et al. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int. J. Cancer 11, 765\u2013773 (1973).","journal-title":"Int. J. Cancer"},{"key":"88307_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jnci\/58.4.881","volume":"58","author":"S Rasheed","year":"1977","unstructured":"Rasheed, S., Gardner, M. B., Rongey, R. W., Nelson-Rees, W. A. & Arnstein, P. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J. Natl. Cancer Inst. 58, 881\u2013890 (1977).","journal-title":"J. Natl. Cancer Inst."},{"key":"88307_CR28","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana, M. & Koide, S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. et Biophys. Acta Proteins Proteom. 1804, 1405\u20131412 (2010).","journal-title":"Biochim. et Biophys. Acta Proteins Proteom."},{"key":"88307_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","volume":"177","author":"H Naiki","year":"1989","unstructured":"Naiki, H., Higuchi, K., Hosokawa, M. & Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal. Biochem. 177, 244\u2013249 (1989).","journal-title":"Anal. Biochem."},{"key":"88307_CR30","doi-asserted-by":"crossref","unstructured":"Xue, C., Lin, T. Y., Chang, D. & Guo, Z. Thioflavin T as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation. R. Soc. Open Sci. 4 (2017).","DOI":"10.1098\/rsos.160696"},{"key":"88307_CR31","doi-asserted-by":"crossref","unstructured":"Gui, X. et al. Liquid-liquid phase separation of amyloid-\u03b2 oligomers modulates amyloid fibrils formation. J. Biol. Chem. 299 (2023).","DOI":"10.1016\/j.jbc.2023.102926"},{"key":"88307_CR32","doi-asserted-by":"crossref","unstructured":"Ambadipudi, S., Biernat, J., Riedel, D., Mandelkow, E. & Zweckstetter, M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein tau. Nat. Commun. 8 (2017).","DOI":"10.1038\/s41467-017-00480-0"},{"key":"88307_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray, S. et al. \u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation. Nat. Chem. 12, 705\u2013716 (2020).","journal-title":"Nat. Chem."},{"key":"88307_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/ageing\/afv009","volume":"44","author":"J Lan","year":"2015","unstructured":"Lan, J. et al. The peripheral blood of A\u03b2 binding RBC as a biomarker for diagnosis of Alzheimer\u2019s disease. Age Ageing. 44, 458\u2013464 (2015).","journal-title":"Age Ageing"},{"key":"88307_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.sbi.2019.05.003","volume":"58","author":"AW Fitzpatrick","year":"2019","unstructured":"Fitzpatrick, A. W. & Saibil, H. R. Cryo-EM of amyloid fibrils and cellular aggregates. Curr. Opin. Struct. Biol. 58, 34\u201342 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"88307_CR36","doi-asserted-by":"publisher","first-page":"1494218","DOI":"10.3389\/fnmol.2024.1494218","volume":"17","author":"ED Ruiz-Ortega","year":"2024","unstructured":"Ruiz-Ortega, E. D., Wilkaniec, A. & Adamczyk, A. Liquid\u2013liquid phase separation and conformational strains of \u03b1-Synuclein: implications for Parkinson\u2019s disease pathogenesis. Front. Mol. Neurosci. 17, 1494218 (2024).","journal-title":"Front. Mol. Neurosci."},{"key":"88307_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ab.2015.07.014","volume":"488","author":"I Randrianjatovo-Gbalou","year":"2015","unstructured":"Randrianjatovo-Gbalou, I., Marcato-Romain, C. E. & Girbal-Neuhauser, E. Quantification of amyloid fibrils using size exclusion chromatography coupled with online fluorescence and ultraviolet detection. Anal. Biochem. 488, 19\u201321 (2015).","journal-title":"Anal. Biochem."},{"key":"88307_CR38","doi-asserted-by":"crossref","unstructured":"Upadhyay, A., Vassar, R. J. & Savas, J. N. Biochemical purification and proteomic characterization of amyloid fibril cores from the brain. J. Vis. Exp. 2022 (2022).","DOI":"10.3791\/63816-v"},{"key":"88307_CR39","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1074\/jbc.M115.699348","volume":"291","author":"R Crespo","year":"2016","unstructured":"Crespo, R. et al. What can the kinetics of amyloid fibril formation tell about off-pathway aggregation? J. Biol. Chem. 291, 2018\u20132032 (2016).","journal-title":"J. Biol. Chem."},{"key":"88307_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/biom10020241","volume":"10","author":"V Balobanov","year":"2020","unstructured":"Balobanov, V. et al. The kinetics of amyloid fibril formation by de novo protein albebetin and its mutant variants. Biomolecules 10, 241 (2020).","journal-title":"Biomolecules"},{"issue":"5","key":"88307_CR41","first-page":"1","volume":"51","author":"D Ghosh","year":"2015","unstructured":"Ghosh, D. et al. Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-Synuclein aggregation. Sci. Rep. 51 (5), 1\u201315 (2015).","journal-title":"Sci. Rep."},{"key":"88307_CR42","first-page":"1","volume":"151","author":"F Farris","year":"2024","unstructured":"Farris, F. et al. Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer. Cell. Death Dis. 151, 1\u201313 (2024).","journal-title":"Cell. Death Dis."},{"key":"88307_CR43","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1093\/bioinformatics\/btm325","volume":"23","author":"Z Zhang","year":"2007","unstructured":"Zhang, Z., Chen, H. & Lai, L. Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23, 2218\u20132225 (2007).","journal-title":"Bioinformatics"},{"key":"88307_CR44","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Conformable self-assembling amyloid protein coatings with genetically programmable functionality. Sci. Adv. 6 (2020).","DOI":"10.1126\/sciadv.aba1425"},{"key":"88307_CR45","doi-asserted-by":"crossref","unstructured":"Upadhyay, A. et al. Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity. Mol. Neurodegener. 18 (2023).","DOI":"10.1186\/s13024-023-00654-z"},{"key":"88307_CR46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/bip.21161","volume":"91","author":"DM Hamburg","year":"2009","unstructured":"Hamburg, D. M., Suh, M. J. & Limbach, P. A. Limited proteolysis analysis of the ribosome is affected by subunit association. Biopolymers 91, 410\u2013422 (2009).","journal-title":"Biopolymers"},{"key":"88307_CR47","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jasms.2007.03.028","volume":"18","author":"MJ Suh","year":"2007","unstructured":"Suh, M. J., Pourshahian, S. & Limbach, P. A. Developing limited proteolysis and mass spectrometry for the characterization of ribosome topography. J. Am. Soc. Mass. Spectrom. 18, 1304\u20131317 (2007).","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"88307_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/bbrc.2000.3682","volume":"277","author":"N Hazeki","year":"2000","unstructured":"Hazeki, N., Tukamoto, T., Goto, J. & Kanazawa, I. Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. Biochem. Biophys. Res. Commun. 277, 386\u2013393 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"88307_CR49","doi-asserted-by":"publisher","first-page":"13036","DOI":"10.1074\/jbc.RA120.013396","volume":"295","author":"LFB Christensen","year":"2020","unstructured":"Christensen, L. F. B., Nowak, J. S., S\u00f8nderby, T. V., Frank, S. A. & Otzen, D. E. Quantitating denaturation by formic acid: imperfect repeats are essential to the stability of the functional amyloid protein FapC. J. Biol. Chem. 295, 13036\u201313041 (2020).","journal-title":"J. Biol. Chem."},{"key":"88307_CR50","doi-asserted-by":"crossref","unstructured":"Casali, B. T. & Landreth, G. E. A\u03b2 extraction from murine brain homogenates. Bio-protocol 6 (2016).","DOI":"10.21769\/BioProtoc.1787"},{"key":"88307_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.014","volume":"1301","author":"DZ Christensen","year":"2009","unstructured":"Christensen, D. Z., Bayer, T. A. & Wirths, O. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal A\u03b2 peptides in mouse models of Alzheimer\u2019s disease. Brain Res. 1301, 116\u2013125 (2009).","journal-title":"Brain Res."},{"key":"88307_CR52","doi-asserted-by":"crossref","unstructured":"Balani, S., Nguyen, L. V. & Eaves, C. J. Modeling the process of human tumorigenesis. Nat. Commun. 8 (2017).","DOI":"10.1038\/ncomms15422"},{"key":"88307_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/2159-8290.CD-14-0788","volume":"5","author":"CL Chaffer","year":"2015","unstructured":"Chaffer, C. L. & Weinberg, R. A. How does multistep tumorigenesis really proceed? Cancer Discov. 5, 22\u201324 (2015).","journal-title":"Cancer Discov"},{"key":"88307_CR54","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","volume":"29","author":"D Ostroverkhova","year":"2023","unstructured":"Ostroverkhova, D., Przytycka, T. M. & Panchenko, A. R. Cancer driver mutations: predictions and reality. Trends Mol. Med. 29, 554\u2013566 (2023).","journal-title":"Trends Mol. Med."},{"key":"88307_CR55","doi-asserted-by":"crossref","unstructured":"Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability \u2014 an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220\u2013228 (2010).","DOI":"10.1038\/nrm2858"},{"key":"88307_CR56","doi-asserted-by":"crossref","unstructured":"Bi, Q. et al. Tumor-associated inflammation: The tumor-promoting immunity in the early stages of tumorigenesis. J. Immunol. Res. 2022 (2022).","DOI":"10.1155\/2022\/3128933"},{"key":"88307_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022.02.007","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro, J., Messal, H. A., Elosegui-Artola, A., van Rheenen, J. & Behrens, A. Tissue architecture in tumor initiation and progression. Trends Cancer 8, 494\u2013505 (2022).","journal-title":"Trends Cancer"},{"key":"88307_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui, L. & Chen, Y. Tumor microenvironment: sanctuary of the devil. Cancer Lett. 368, 7\u201313 (2015).","journal-title":"Cancer Lett."},{"key":"88307_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1158\/1541-7786.MCR-19-1158","volume":"18","author":"KJ Pienta","year":"2020","unstructured":"Pienta, K. J. et al. Convergent evolution, evolving evolvability, and the origins of lethal cancer. Mol. Cancer Res. 18, 801\u2013810 (2020).","journal-title":"Mol. Cancer Res."},{"key":"88307_CR60","doi-asserted-by":"crossref","unstructured":"Shomar, A. & Barak, O. & Brenner, N. Cancer progression as a learning process. iScience 25 (2022).","DOI":"10.1016\/j.isci.2022.103924"},{"key":"88307_CR61","doi-asserted-by":"publisher","first-page":"28152","DOI":"10.1074\/jbc.M112.340638","volume":"287","author":"APD Ano Bom","year":"2012","unstructured":"Ano Bom, A. P. D. et al. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J. Biol. Chem. 287, 28152\u201328162 (2012).","journal-title":"J. Biol. Chem."},{"key":"88307_CR62","doi-asserted-by":"crossref","unstructured":"Degoricija, M. et al. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice. J. Transl. Med. 17 (2019).","DOI":"10.1186\/s12967-019-02146-5"},{"key":"88307_CR63","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","volume":"37","author":"D Fantini","year":"2018","unstructured":"Fantini, D. et al. A carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer. Oncogene 37, 1911\u20131925 (2018).","journal-title":"Oncogene"},{"key":"88307_CR64","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/10409238.2021.1937926","volume":"56","author":"J Gottwald","year":"2021","unstructured":"Gottwald, J. & R\u00f6cken, C. The amyloid proteome: a systematic review and proposal of a protein classification system. Crit. Rev. Biochem. Mol. Biol. 56, 526\u2013542 (2021).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"88307_CR65","doi-asserted-by":"crossref","unstructured":"Drummond, E. et al. The amyloid plaque proteome in early onset Alzheimer\u2019s disease and down syndrome. Acta Neuropathol. Commun. 10 (2022).","DOI":"10.1186\/s40478-022-01356-1"},{"key":"88307_CR66","doi-asserted-by":"publisher","first-page":"37061","DOI":"10.1074\/jbc.M403672200","volume":"279","author":"L Liao","year":"2004","unstructured":"Liao, L. et al. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 279, 37061\u201337068 (2004).","journal-title":"J. Biol. Chem."},{"key":"88307_CR67","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong, F., Ge, W. & Ma, C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease. Alzheimers Dement. 15, 429\u2013440 (2019).","journal-title":"Alzheimers Dement."},{"key":"88307_CR68","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.2741\/2973","volume":"13","author":"Q Xia","year":"2008","unstructured":"Xia, Q. et al. Proteomic identification of novel proteins associated with Lewy bodies. Front. Biosci. 13, 3850\u20133856 (2008).","journal-title":"Front. Biosci."},{"key":"88307_CR69","doi-asserted-by":"crossref","unstructured":"Ulamec, S. M., Brockwell, D. J. & Radford, S. E. Looking beyond the core: the role of flanking regions in the aggregation of amyloidogenic peptides and proteins. Front. Neurosci. 14 (2020).","DOI":"10.3389\/fnins.2020.611285"},{"key":"88307_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cell.2010.11.050","volume":"144","author":"H Olzscha","year":"2011","unstructured":"Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67\u201378 (2011).","journal-title":"Cell"},{"key":"88307_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jare.2021.05.007","volume":"36","author":"KJY Low","year":"2022","unstructured":"Low, K. J. Y., Venkatraman, A., Mehta, J. S. & Pervushin, K. Molecular mechanisms of amyloid disaggregation. J. Adv. Res. 36, 113 (2022).","journal-title":"J. Adv. Res."},{"key":"88307_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-biochem-061516-045104","volume":"86","author":"DS Eisenberg","year":"2017","unstructured":"Eisenberg, D. S. & Sawaya, M. R. Structural studies of amyloid proteins at the molecular level. Annu. Rev. Biochem. 86, 69\u201395 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"88307_CR73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.31083\/j.fbl2903092","volume":"29","author":"A Qiu","year":"2024","unstructured":"Qiu, A. et al. Phosphoglycerate kinase 1: an effective therapeutic target in cancer. Front. Biosci. Landmark. 29, 92 (2024).","journal-title":"Front. Biosci. - Landmark"},{"key":"88307_CR74","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/biom3041030","volume":"3","author":"G Valentini","year":"2013","unstructured":"Valentini, G., Maggi, M. & Pey, A. L. Protein Stability, folding and misfolding in human PGK1 deficiency. Biomolecules 3, 1030\u20131052 (2013).","journal-title":"Biomolecules"},{"key":"88307_CR75","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10545-014-9721-8","volume":"37","author":"AL Pey","year":"2014","unstructured":"Pey, A. L., Maggi, M. & Valentini, G. Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses. J. Inherit. Metab. Dis. 37, 909\u2013916 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"88307_CR76","doi-asserted-by":"crossref","unstructured":"Rahman, M. M. & Lendel, C. Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol. Neurodegener. 16 (2021).","DOI":"10.1186\/s13024-021-00465-0"},{"key":"88307_CR77","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/dnares\/dsl016","volume":"13","author":"JM Kim","year":"2006","unstructured":"Kim, J. M. et al. Identification of genes related to Parkinson\u2019s disease using expressed sequence tags. DNA Res. 13, 275\u2013286 (2006).","journal-title":"DNA Res."},{"issue":"3","key":"88307_CR78","first-page":"1","volume":"31","author":"S Sakaue","year":"2017","unstructured":"Sakaue, S. et al. Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism? NPJ Park Dis. 31 (3), 1\u20133 (2017).","journal-title":"NPJ Park Dis."},{"key":"88307_CR79","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/mdc3.12055","volume":"1","author":"T Virmani","year":"2014","unstructured":"Virmani, T. et al. Levodopa responsive parkinsonism in two patients with phosphoglycerate kinase deficiency. Mov. Disord. Clin. Pract. 1, 240\u2013242 (2014).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"88307_CR80","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.21612","volume":"41","author":"E Sotiriou","year":"2010","unstructured":"Sotiriou, E., Greene, P., Krishna, S., Hirano, M. & DiMauro, S. Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle Nerve 41, 707\u2013710 (2010).","journal-title":"Muscle Nerve"},{"key":"88307_CR81","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0022-3476(73)80120-9","volume":"82","author":"PN Konrad","year":"1973","unstructured":"Konrad, P. N., McCarthy, D. J., Mauer, A. M., Valentine, W. N. & Paglia, D. E. Erythrocyte and leukocyte phosphoglycerate kinase deficiency with neurologic disease. J. Pediatr. 82, 456\u2013460 (1973).","journal-title":"J. Pediatr."},{"key":"88307_CR82","doi-asserted-by":"publisher","first-page":"e32065","DOI":"10.1371\/journal.pone.0032065","volume":"7","author":"LR Chiarelli","year":"2012","unstructured":"Chiarelli, L. R. et al. Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency. PLoS One 7, e32065 (2012).","journal-title":"PLoS One"},{"key":"88307_CR83","doi-asserted-by":"crossref","unstructured":"Fiorillo, A. et al. The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme. PLoS One 13, (2018).","DOI":"10.1371\/journal.pone.0199191"},{"key":"88307_CR84","first-page":"2280","volume":"9","author":"Y He","year":"2019","unstructured":"He, Y. et al. PGK1-mediated cancer progression and drug resistance. Am. J. Cancer Res. 9, 2280 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"88307_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-023-01256-4","volume":"21","author":"K Zhang","year":"2023","unstructured":"Zhang, K., Sun, L. & Kang, Y. Regulation of phosphoglycerate kinase 1 and its critical role in cancer. Cell. Commun. Signal. 21, 1\u201315 (2023).","journal-title":"Cell. Commun. Signal."},{"key":"88307_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10010046","volume":"10","author":"N Datta","year":"2020","unstructured":"Datta, N., Chakraborty, S., Basu, M. & Ghosh, M. K. Tumor suppressors having oncogenic functions: the double agents. Cells 10, 1\u201326 (2020).","journal-title":"Cells"},{"key":"88307_CR87","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/BST20130010","volume":"41","author":"RDW Kelly","year":"2013","unstructured":"Kelly, R. D. W. & Cowley, S. M. The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts. Biochem. Soc. Trans. 41, 741\u2013749 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"88307_CR88","doi-asserted-by":"publisher","first-page":"108190","DOI":"10.1016\/j.pharmthera.2022.108190","volume":"238","author":"C Brancolini","year":"2022","unstructured":"Brancolini, C., Gagliano, T. & Minisini, M. HDACs and the epigenetic plasticity of cancer cells: target the complexity. Pharmacol. Ther. 238, 108190 (2022).","journal-title":"Pharmacol. Ther."},{"key":"88307_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/1535-7163.MCT-15-0618","volume":"15","author":"M Pinkerneil","year":"2016","unstructured":"Pinkerneil, M. et al. Inhibition of class I histone deacetylases 1 and 2 promotes urothelial carcinoma cell death by various mechanisms. Mol. Cancer Ther. 15, 299\u2013312 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"88307_CR90","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"Jaffe, A. B. & Hall, A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell. Dev. Biol. 21, 247\u2013269 (2005).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"88307_CR91","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4161\/sgtp.25131","volume":"4","author":"KL O\u2019Connor","year":"2013","unstructured":"O\u2019Connor, K. L. & Chen, M. Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases. 4, 141 (2013).","journal-title":"Small GTPases"},{"key":"88307_CR92","doi-asserted-by":"publisher","unstructured":"Blake, D. R. & Der, C. J. RHOA mutations in cancer: oncogenes or tumor suppressors? Rho GTPases Mol. Biol. Heal. Dis. 121\u2013138. https:\/\/doi.org\/10.1142\/9789813228795_0007 (2017).","DOI":"10.1142\/9789813228795_0007"},{"key":"88307_CR93","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/abbs\/gmu051","volume":"46","author":"G Yan","year":"2014","unstructured":"Yan, G. et al. Silencing RhoA inhibits migration and invasion through Wnt\/\u03b2-catenin pathway and growth through cell cycle regulation in human tongue cancer. Acta Biochim. Biophys. Sin. (Shanghai) 46, 682\u2013690 (2014).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"88307_CR94","doi-asserted-by":"publisher","first-page":"8694","DOI":"10.1158\/0008-5472.CAN-04-2247","volume":"64","author":"KJ Simpson","year":"2004","unstructured":"Simpson, K. J., Dugan, A. S. & Mercurio, A. M. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res. 64, 8694\u20138701 (2004).","journal-title":"Cancer Res."},{"key":"88307_CR95","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1210\/me.2011-1130","volume":"26","author":"LJ Schmidt","year":"2012","unstructured":"Schmidt, L. J. et al. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol. Endocrinol. 26, 716 (2012).","journal-title":"Mol. Endocrinol."},{"key":"88307_CR96","unstructured":"Faustmann, P. The role of Grainyhead-like 3 Transcription Factor (Ulm University, 2023)."},{"key":"88307_CR97","doi-asserted-by":"crossref","unstructured":"\u0160ulskis, D., \u017diaunys, M., Sakalauskas, A., Snie\u010dkute, R. & Smirnovas, V. Formation of amyloid fibrils by the regulatory 14-3-3\u03b6 protein. Open. Biol. 14 (2024).","DOI":"10.1098\/rsob.230285"},{"key":"88307_CR98","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2020.04.001","volume":"6","author":"Y Takamatsu","year":"2020","unstructured":"Takamatsu, Y., Ho, G. & Hashimoto, M. Amyloid evolvability and cancer. Trends Cancer 6, 624\u2013627 (2020).","journal-title":"Trends Cancer"},{"key":"88307_CR99","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/JIR.S404900","volume":"16","author":"H Ding","year":"2023","unstructured":"Ding, H. et al. Serum amyloid a predicts prognosis and chemotherapy efficacy in patients with advanced pancreatic cancer. J. Inflamm. Res. 16, 1297 (2023).","journal-title":"J. Inflamm. Res."},{"key":"88307_CR100","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"88307_CR101","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nprot.2006.4","volume":"1","author":"H Sch\u00e4gger","year":"2006","unstructured":"Sch\u00e4gger, H. Tricine-SDS-PAGE. Nat. Protoc. 1, 16\u201322 (2006).","journal-title":"Nat. Protoc."},{"key":"88307_CR102","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"88307_CR103","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576e16 (2017).","journal-title":"Cell"},{"key":"88307_CR104","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"88307_CR105","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"88307_CR106","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"88307_CR107","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"88307_CR108","doi-asserted-by":"crossref","unstructured":"Tsolis, A. C., Papandreou, N. C., Iconomidou, V. A. & Hamodrakas, S. J. A Consensus method for the prediction of \u2018Aggregation-Prone\u2019 peptides in globular proteins. PLoS One 8, (2013).","DOI":"10.1371\/journal.pone.0054175"},{"key":"88307_CR109","doi-asserted-by":"crossref","unstructured":"Conchillo-Sol\u00e9, O. et al. AGGRESCAN: a server for the prediction and evaluation of \u2018hot spots\u2019 of aggregation in polypeptides. BMC Bioinform. 8 (2007).","DOI":"10.1186\/1471-2105-8-65"},{"key":"88307_CR110","doi-asserted-by":"crossref","unstructured":"Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40, 1023\u20131025 (2022).","DOI":"10.1038\/s41587-021-01156-3"},{"key":"88307_CR111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/pro.4172","volume":"31","author":"M Kanehisa","year":"2022","unstructured":"Kanehisa, M., Sato, Y. & Kawashima, M. KEGG mapping tools for uncovering hidden features in biological data. Protein Sci. 31, 47\u201353 (2022).","journal-title":"Protein Sci."},{"key":"88307_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"88307_CR113","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"88307_CR114","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"88307_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle, H. et al. A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 16, 1\u20137 (2015).","journal-title":"BMC Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88307-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T19:03:17Z","timestamp":1738782197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88307-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88307"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88307-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4393"}}